These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25392001)

  • 1. How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.
    Fan VY; Glassman A; Silverman RL
    Health Aff (Millwood); 2014 Dec; 33(12):2238-46. PubMed ID: 25392001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
    Avdeeva O; Lazarus JV; Aziz MA; Atun R
    J Int AIDS Soc; 2011 Oct; 14():51. PubMed ID: 22029667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global health development assistance remained steady in 2013 but did not align with recipients' disease burden.
    Dieleman JL; Graves CM; Templin T; Johnson E; Baral R; Leach-Kemon K; Haakenstad AM; Murray CJ
    Health Aff (Millwood); 2014 May; 33(5):878-86. PubMed ID: 24714869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human rights and the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
    Davis SL
    Health Hum Rights; 2014 Jun; 16(1):134-47. PubMed ID: 25474602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.
    Lu C; Michaud CM; Khan K; Murray CJ
    Lancet; 2006 Aug; 368(9534):483-8. PubMed ID: 16890835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investing to end epidemics: the role of the Global Fund to control TB by 2030.
    Kunii O; Yassin MA; Wandwalo E
    Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):153-4. PubMed ID: 26884492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fraud at the Global Fund? A viewpoint.
    Brown JC; Griekspoor W
    Int J Health Plann Manage; 2013; 28(1):138-43. PubMed ID: 23238987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusive engagement for health and development or 'political theatre': results from case studies examining mechanisms for country ownership in Global Fund processes in Malawi, Tanzania and Zimbabwe.
    Armstrong R; Campbell White A; Chinyamuchiko P; Chizimbi S; Hamm Rush S; Poku NK
    Global Health; 2019 May; 15(1):34. PubMed ID: 31064386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking local knowledge with global action: examining the Global Fund to Fight AIDS, Tuberculosis and Malaria through a knowledge system lens.
    van Kerkhoff L; Szlezák N
    Bull World Health Organ; 2006 Aug; 84(8):629-35. PubMed ID: 16917650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allocating scarce resources strategically--an evaluation and discussion of the Global Fund's pattern of disbursements.
    McCoy D; Kinyua K
    PLoS One; 2012; 7(5):e34749. PubMed ID: 22590496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meaningful change or more of the same? The Global Fund's new funding model and the politics of HIV scale-up.
    Kapilashrami A; Hanefeld J
    Glob Public Health; 2014; 9(1-2):160-75. PubMed ID: 24499023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grant Performance and Health Financing: Analysis of 12 Years of Financing Decisions at the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Tran Ba Huy R; Fink G; Olszak-Olszewski M; Reich MR
    Health Syst Reform; 2015 May; 1(4):301-312. PubMed ID: 31519096
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementing Global Fund programs: a survey of opinions and experiences of the Principal Recipients across 69 countries.
    Wafula F; Marwa C; McCoy D
    Global Health; 2014 Mar; 10():15. PubMed ID: 24661793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality changes after grants from the Global Fund to Fight AIDS, tuberculosis and malaria: an econometric analysis from 1995 to 2010.
    Yan I; Korenromp E; Bendavid E
    BMC Public Health; 2015 Sep; 15():977. PubMed ID: 26416543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.